脂蛋白_a_致动脉粥样硬化作用机制研究进展_贺艳丽.pdfVIP

80 ISSN 1007-3949 Chin J Arterioscler, Vol 10, No 1 of the obesitymutation, . fatty. , on apolipoprotein gene regulation in rat liver. Int familial combined hyperlipidemia. J Lip id Res, 1999, 40 (6) : 1036-044 J Obes RelatMetab Disord, 2000, 24( 4) : 460-467 [ 15] Dallongeville J, Meirhaghe A, Cottel D, et al. Gender related association be- [ 7] hang L-H, Kotite L, Havel RJ. Identification, characterization, cloning and ex- tween genetic variations of apo C Ó gene and lipid and lipoprotein variables Fin pression of apolipoprotein CÔ, a novel sialoglycoprotein of rabbit plasma lipopro- northern France. Atherosclerosis, 2000, 150 ( 1) : 149- 157 teins. J Biol Chem, 1996, 271: 1 776-783 [ 16] Jong MC, DahlmansVEH, van Gorp PJJ, et al. In the absenceof the low densi- [ 8] JongMC, Hofker MH, Havekes LM. Role of apo Cs in lipoprotein metabolism: ty lipoprotein receptor, human apolipoprotein C1overexpression in transgenic mice Functional differences between apoC1, apoC2, and apoC3. Arterioscler Thromb inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated Vasc Biol, 1999, 19: 472-484 protein-sensitive pathway. J ClinInvest, 1996, 98: 2 259-267 [ 9] Yamamoto M, Katoh N, Oilawa S. Evaluation of serum apolipoprotein CÓ con- [17] Swaney JB, Weisgraber KH. Effects of apolipoprotein C Ñ peptides on the centration by enzyme-linked immunosorbent assay and its higher concentration in apolipoprotein E content and receptor-binding properties of -migrating very low cowa during midlactation then during the nonlactating stage. Am J Vet Res, 1998, density lipoproteins. J Lip id Res, 1994, 35: 134- 142 59 ( 11) : 1358-363 [ 18] Shachter NS, Hayek T, Leff T, et al. Overexpression of ap